Mechanism of the Furin cleavage site in the function of SARS-CoV-2 spike protein

I. Discovery of the Furin Protease Cleavage Site and Initial Hypothesis

The spike protein of the novel coronavirus plays a critical role in mediating viral entry into host cells. Early bioinformatics analyses, particularly through multiple sequence alignments, revealed a unique insertion sequence "PRRA" at the S1/S2 subunit junction of the SARS-CoV-2 spike protein, which is relatively rare in other known coronaviruses. This sequence constitutes a potential cleavage site for Furin protease (PCSK3). Based on this, the scientific community proposed the hypothesis that this Furin cleavage site might be an important molecular basis for SARS-CoV-2's enhanced transmissibility compared to viruses like SARS-CoV, resembling mechanisms observed in some highly pathogenic influenza viruses. Further exploration of Furin inhibitors as potential therapeutic strategies was also initiated.

II. Furin Protease (PCSK3) and the Application Value of Purified Protein in Research

To deeply investigate the function of this cleavage site, obtaining high-purity, high-activity Furin protease (PCSK3) is crucial. Furin/PCSK3 His Tag Protein, as a commonly used research tool, features a C- or N-terminal histidine tag (His-Tag) that facilitates efficient purification via metal chelation chromatography, yielding high-purity protein preparations free of other protease impurities. This recombinant protein can be used for:

1. In vitro cleavage validation: Directly verifying the cleavage efficiency and specificity of Furin protease on wild-type and mutant SARS-CoV-2 spike proteins (or their S1/S2 recombinant peptides) in in vitro biochemical reaction systems.

2. Enzyme kinetics studies: Quantitatively analyzing kinetic parameters (e.g., Km, Kcat) of the cleavage reaction and evaluating differences among various spike protein variants as substrates.

3. Inhibitor screening platforms: Serving as a target protein for high-throughput screening or assessing the activity and efficacy of potential Furin protease inhibitors.

III. Experimental Analysis of Furin Cleavage Site Function and Context Dependence

Recently, a team from Fudan University systematically validated the function of the Furin cleavage site through cell-based membrane fusion experiments, revealing its functional complexity.

1. Confirmation of Furin cleavage and basic function: The study first confirmed that the wild-type SARS-CoV-2 spike protein containing the "PRRA" sequence could be effectively cleaved and processed by Furin protease in cells, whereas deletion or substitution mutants of this sequence were not cleaved. This indicates that this site is indeed a target for Furin in cells.

2. Function in the absence of exogenous proteases: In cell-cell fusion models lacking exogenous proteases (e.g., trypsin), spike proteins with a functional Furin cleavage site exhibited stronger membrane fusion activity. This supports the notion that Furin cleavage, under specific conditions, can promote spike protein activation and thereby enhance its membrane fusion function.

3. Functional redundancy in the presence of exogenous proteases: When exogenous trypsin-like proteases were present in the experimental system, spike protein mutants lacking the Furin cleavage site could still be effectively activated and mediate efficient membrane fusion, with effects showing enzyme concentration dependence. This key finding suggests that in physiological environments rich in such proteases (e.g., the respiratory tract), Furin cleavage may not be the sole or essential pathway for spike protein activation, and its function exhibits certain redundancy and context dependence.

IV. Conclusions and Prospects: From Mechanistic Research to Tool Applications

Integrating existing research, the Furin protease cleavage site in the SARS-CoV-2 spike protein is an important functional element, but its absolute necessity in viral entry may vary depending on the microenvironment (e.g., local protease types and abundance). The presence of this site more likely provides the virus with an additional, and in certain contexts, more efficient activation pathway, thereby conferring a transmission advantage rather than being a strict survival requirement. This study highlights the importance of validating molecular mechanisms in physiologically relevant environments.

For follow-up research, high-quality recombinant tool proteins such as Furin/PCSK3 His Tag Protein will continue to play a central role. Researchers can use them to more precisely simulate the cleavage process in vitro, combine structural biology approaches to resolve enzyme-substrate complex structures, and explore changes in Furin cleavage sensitivity among different spike protein variants. These in-depth fundamental studies will not only contribute to a more comprehensive understanding of viral pathogenesis but also provide critical scientific basis for evaluating broad-spectrum antiviral strategies targeting this pathway.

V. Which Manufacturers Provide Furin/PCSK3 His Tag Protein?

Nanjing UA Protein independently developed Furin/PCSK3 His Tag Protein, Human (Catalog No.: UA011272), a high-purity, high-activity human Furin (also known as PCSK3) recombinant protein. It is produced using a mammalian expression system and carries a C-terminal His tag for purification and detection. Furin is an important proprotein convertase widely involved in the cleavage and activation of various precursor proteins, including growth factors, hormones, viral proteins, and cell surface receptors. This product is suitable for enzyme activity studies, substrate specificity analysis, inhibitor screening, and cell signaling regulation, providing you with a reliable and efficient research tool.

Nanjing UA Protein is committed to providing high-quality, high-performance recombinant protein tools for cell biology, disease mechanism research, and innovative drug development. For detailed technical parameters, enzyme activity validation data, or application guidance regarding Furin/PCSK3 His Tag Protein, Human (Catalog No.: UA011272), please feel free to contact us.